Its fine… their annual EBITDA is going to be roughly 230crs for FY25. Assuming a 60% cash conversion, that comes out to be ~140crs. On top of it they have around 80-100crs on balance sheet? They can go aggressive while continuing to grow the existing hospitals which don’t need a lot of capital investments.
| Subscribe To Our Free Newsletter |
